Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MAX HEALTHCARE INSTITUTE Quarterly Results  (MAXH)



Here are the latest quarterly results of MAX HEALTHCARE INSTITUTE. For more details, see the MAX HEALTHCARE INSTITUTE financial fact sheet and MAX HEALTHCARE INSTITUTE share price. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

MAX HEALTHCARE INSTITUTE Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-22
*
3
Mar-23
*
3
Jun-23
*
3
Sep-23
*
3
Dec-23
*
3
Mar-24
*
3
Jun-24
*
3
Sep-24
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m11,41812,14512,85013,63213,35014,22915,43017,075 
Other income Rs m446402413455460453347408 
Turnover Rs m11,86412,54713,26314,08613,81014,68215,77617,483 
Expenses Rs m8,2788,7429,4769,7589,49110,41411,55512,569 
Gross profit Rs m3,1403,4033,3743,8743,8593,8153,8744,505 
Depreciation Rs m570604558579610703769842 
Interest Rs m20119519485112207239335 
Profit before tax Rs m2,8143,0073,0353,6643,5973,3573,2133,737 
Tax Rs m590498634897703842850919 
Profit after tax Rs m2,2242,5092,4012,7672,8932,5152,3632,818 
Gross profit margin %27.528.026.328.428.926.825.126.4 
Effective tax rate %21.016.520.924.519.625.126.524.6 
Net profit margin %19.520.718.720.321.717.715.316.5 
Diluted EPS Rs 2.3 2.6 2.5 2.8 3.0 2.6 2.4 2.9  
Diluted EPS (TTM) Rs 10.0 11.4 12.0 10.2 10.9 10.9 10.8 10.9  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Today's Market

AstraZeneca Pharma Receives CDSCO Approval | Why Defence Stocks are Rising | Top Buzzing Stocks Today AstraZeneca Pharma Receives CDSCO Approval | Why Defence Stocks are Rising | Top Buzzing Stocks Today(Pre-Open)

Indian benchmark indices remained volatile as the session progressed and ended the day lower.